Pzena Investment Management
ALXN

Pzena Investment Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Pzena Investment Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-3,430
Closed -$630K – 177
2021
Q2 		$630K Sell
3,430
-795
-19% -$136K ﹤0.01% 138
2021
Q1 		$646K Buy
4,225
+176
+4% +$27.2K ﹤0.01% 151
2020
Q4 		$633K Sell
4,049
-874
-18% -$112K ﹤0.01% 152
2020
Q3 		$563K Sell
4,923
-1,062
-18% -$115K ﹤0.01% 148
2020
Q2 		$672K Sell
5,985
-1,632
-21% -$173K ﹤0.01% 152
2020
Q1 		$684K Buy
+7,617
New +$748K 0.01% 148

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return